Journal profile · Immunology
International Reviews of Immunology
ISSN 0883-0185 · eISSN 1563-5244 · Informa Healthcare · ENGLAND · Bimonthly · Founded 1986
International Reviews of Immunology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 5.3; JCR Q2 (journal website); hybrid open access; APC charged, amount not published; median 188 days to acceptance (42 articles, last 24 months); community-reported acceptance: moderate; 16 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
International Reviews of Immunology is published by Informa Healthcare and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are T-cell and B-cell Immunology, Immune Cell Function and Interaction and Immunotherapy and Immune Responses, together about 44.9% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
International Reviews of Immunology, founded in 1986, is an internationally reputed immunology journal showcasing advancement in immunology. A wide and deep understanding of immunity with exceptional tools and techniques not only unveils the exciting biology of human health and disease but also provides insights for precise diagnosis and therapy. The journal publishes Review Articles highlighting advances in the broad field of immunology and related areas associated with human health. The journal is committed to the rapid dissemination of the latest growing novel ideas proved by worldwide acceptable state-of-the-art methods. This journal publishes the most recent and high-standard articles and the submissions are being reviewed by experts in the field. An international board of editors makes sure that the articles are interesting to a broad readership of immunology. International Reviews of Immunology accepts Review Articles and Editorials (Editors and Special Issues only) for publication. From 2026, the Print ISSN is not in active use as this journal is no longer published in print.
From the journal's Aims & Scope
Research area (LetPub): Immunology
Editor-in-chief Himanshu KumarPublisher website
Editorial board by country: 2 in mainland China (about 6%); most named United States 11, Italy 8, Mainland China 2, Japan 2, Australia 2 (31 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- T-cell and B-cell ImmunologyImmunology and Microbiology17.6%
- Immune Cell Function and InteractionImmunology and Microbiology15.9%
- Immunotherapy and Immune ResponsesImmunology and Microbiology11.4%
- Monoclonal and Polyclonal Antibodies ResearchMedicine10.2%
- Immune Response and InflammationImmunology and Microbiology4.2%
- Diabetes and associated disordersBiochemistry, Genetics and Molecular Biology3.5%
- CAR-T cell therapy researchMedicine2.9%
- Glycosylation and Glycoproteins ResearchBiochemistry, Genetics and Molecular Biology2.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: yes
JCR / CiteScore quartiles on the journal's website
- JCR Q2 · best quartile · 2025
- CiteScore Q1 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPubMedEmbaseCAB AbstractsCurrent ContentsPublisher website
Other: Adis International Ltd. - Reactions Weekly (Online), EBSCOhost - Academic Search Alumni Edition, Elsevier BV - BIOBASE, Thomson Reuters - BIOSIS Previews
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.3LetPub ·
- Impact factor (publisher) 2025
- 5.4Publisher website ·
- 5-year impact factor (publisher) 2025
- 5.4Publisher website ·
- CiteScore 2026-06
- 13.4LetPub ·
- CiteScore (publisher) 2025
- 13.4Publisher website ·
- SJR 2026-06
- 1.65LetPub ·
- SJR (publisher) 2025
- 1.65Publisher website ·
- SNIP 2026-06
- 1.15LetPub ·
- SNIP (publisher) 2025
- 1.15Publisher website ·
- h-index
- 61LetPub ·
- h-index
- 93OpenAlex ·
- i10-index
- 811OpenAlex ·
- 2-year mean citedness
- 6.11OpenAlex ·
- Self-citation rate
- 1.9%LetPub ·
- Share of gold OA articles
- 5.77%LetPub ·
Volume
- Articles per year
- 15LetPub ·
- Downloads per year (publisher)
- 75,000Publisher website ·
Articles by year OpenAlex count · 1,240 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 20 | 1 | 12 |
| 2025 | 16 | 1 | 57 |
| 2024 | 26 | 5 | 310 |
| 2023 | 11 | 0 | 152 |
| 2022 | 25 | 8 | 356 |
| 2021 | 54 | 16 | 1,548 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
188 daysMedian, submission to acceptance · P25–P75 153 days – 338 days
- Acceptance to online
- median 16 days (42 articles)
- Submission to online
- median 224 days
- Sample
- 42 articles with submission and acceptance dates (45 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average acceptance (community reports)
- ModerateLetPub ·
- Acceptance rate (publisher)
- 11%Publisher website ·
- Submission to first decision
- 13 daysPublisher website ·
- First decision after review
- 102 daysPublisher website ·
- Acceptance to publication
- 13 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted2
- editorials (editors and special issues only)International Reviews of Immunology accepts Review Articles and Editorials (Editors and Special Issues only) for publication.Length not stated
- review articlesInternational Reviews of Immunology accepts Review Articles and Editorials (Editors and Special Issues only) for publication.Length not stated
Policy excerpts from the journal's websiteOpen access, Peer review
- Open access Open access
International Reviews of Immunology is a hybrid open access journal that is part of the Taylor & Francis Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the discove…
Source ↗Publisher website ·- Peer review
Rigorous peer review for every open access article Model summary
Rigorous peer review for every open access article
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Informa Healthcare
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1986
- ISSN
- 0883-0185
- Electronic ISSN
- 1563-5244
- Latest issue on the website
- Volume 45, Issue 5 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about International Reviews of Immunology
What CAS zone is International Reviews of Immunology in?
In the 2025 upgraded edition of the CAS Journal Ranking, International Reviews of Immunology is in Zone 4 of Medicine, and in Zone 4 of the minor category Immunology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of International Reviews of Immunology?
The latest impact factor listed by LetPub is 5.3; CiteScore 13.4, h-index 93.
How long does peer review take at International Reviews of Immunology?
Based on the dates recorded on 42 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 188 days (interquartile range 153–338 days); the community-reported acceptance is “Moderate”; the journal's website gives an acceptance rate of 11%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is International Reviews of Immunology in?
The journal's website gives JCR Q2 (best quartile). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Where are the editorial board members of International Reviews of Immunology based?
Of the 31 board members whose country the journal's board page names, 2 (about 6%) are in mainland China; the countries named most often are United States (11), Italy (8) and Mainland China (2). Counted from the institutions listed on the board page; for reference only.
Which databases index International Reviews of Immunology?
According to LetPub and DOAJ records, International Reviews of Immunology is indexed in SCIE and Scopus. The journal's website also lists Web of Science, MEDLINE, PubMed, Embase, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is International Reviews of Immunology open access, and what is the APC?
International Reviews of Immunology is a hybrid journal. For open-access publication: APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .